Trial · NCT00471237
Results by group718
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 718
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Change From Baseline in Bone Marrow Density (BMD) at Month 12 Measured by Dual-Energy X-Ray Absorptiometry (DXA) Scans of the Lumbar Spine (L1-L4) | Placebo | 0.03 | Standard Error 0.38 | Percent change in BMD | |
| Percent Change From Baseline in Bone Marrow Density (BMD) at Month 12 Measured by Dual-Energy X-Ray Absorptiometry (DXA) Scans of the Lumbar Spine (L1-L4) | Ronacaleret, 100 mg Tablet, OD | 0.32 | Standard Error 0.40 | Percent change in BMD | |
| Percent Change From Baseline in Bone Marrow Density (BMD) at Month 12 Measured by Dual-Energy X-Ray Absorptiometry (DXA) Scans of the Lumbar Spine (L1-L4) | Ronacaleret, 200 mg Tablet, OD | 1.39 | Standard Error 0.40 | Percent change in BMD | |
| Percent Change From Baseline in Bone Marrow Density (BMD) at Month 12 Measured by Dual-Energy X-Ray Absorptiometry (DXA) Scans of the Lumbar Spine (L1-L4) | Ronacaleret, 300 mg Tablet, OD | 1.61 | Standard Error 0.39 | Percent change in BMD | |
| Percent Change From Baseline in Bone Marrow Density (BMD) at Month 12 Measured by Dual-Energy X-Ray Absorptiometry (DXA) Scans of the Lumbar Spine (L1-L4) | Ronacaleret, 400 mg Tablet, OD | 1.62 | Standard Error 0.40 | Percent change in BMD | |
| Percent Change From Baseline in Bone Marrow Density (BMD) at Month 12 Measured by Dual-Energy X-Ray Absorptiometry (DXA) Scans of the Lumbar Spine (L1-L4) | Alendronate, 70 mg, Capsule, OW | 4.54 | Standard Error 0.40 | Percent change in BMD | |
| Number of Participants With Hypercalcemia | Placebo | 0 | Participants | ||
| Number of Participants With Hypercalcemia | Ronacaleret, 100 mg Tablet, OD | 1 | Participants | ||
| Number of Participants With Hypercalcemia | Ronacaleret, 200 mg Tablet, OD | 1 | Participants | ||
| Number of Participants With Hypercalcemia | Ronacaleret, 300 mg Tablet, OD | 4 | Participants | ||
| Number of Participants With Hypercalcemia | Ronacaleret, 400 mg Tablet, OD | 11 | Participants | ||
| Number of Participants With Hypercalcemia | Alendronate, 70 mg, Capsule, OW | 0 | Participants | ||
| Number of Participants With Hypercalcemia | Teriparatide, 20 mcg, SC Injection, OD | 1 | Participants | ||
| Number of Participants Withdrew Due to Hypercalcemia | Placebo | 0 | Participants | ||
| Number of Participants Withdrew Due to Hypercalcemia | Ronacaleret, 100 mg Tablet, OD | 0 | Participants | ||
| Number of Participants Withdrew Due to Hypercalcemia | Ronacaleret, 200 mg Tablet, OD | 0 | Participants | ||
| Number of Participants Withdrew Due to Hypercalcemia | Ronacaleret, 300 mg Tablet, OD | 0 | Participants | ||
| Number of Participants Withdrew Due to Hypercalcemia | Ronacaleret, 400 mg Tablet, OD | 0 | Participants | ||
| Number of Participants Withdrew Due to Hypercalcemia | Alendronate, 70 mg, Capsule, OW | 0 | Participants | ||
| Number of Participants Withdrew Due to Hypercalcemia | Teriparatide, 20 mcg, SC Injection, OD | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00471237/results